A major highlight of 2025 was the rapid progress in artificial intelligence (AI) for the detection and assessment of VHD.

The Amend system delivers a closed, D-shaped, semi-rigid annuloplasty ring through a catheter in a transseptal approach.

Obstructive hypertrophic cardiomyopathy symptoms such as trouble breathing, a racing heart, and fatigue can make daily tasks ...

WILMINGTON, Del., Feb. 11, 2026 /PRNewswire/ -- Valcare Medical, Inc., a pioneer developer in transcatheter mitral valve repair solutions, today announced the successful first U.S. transseptal ...

Edwards Lifesciences logged lower profit in its latest quarter despite higher sales, boosted by growth in its transcatheter aortic valve replacement segment. The company on Tuesday posted a profit of ...

Abbott (NYSE: ABT) has reported new data supporting its Tendyne transcatheter mitral valve replacement (TMVR) system.

Edwards Lifesciences reports strong Q4 2025 results with 13.3% sales growth to $1.57B, driven by TAVR and TMTT performance ...

BACKGROUND: Recent randomized trials have demonstrated that for patients with severe tricuspid regurgitation (TR), transcatheter tricuspid valve interventions (TTVI) improve patients’ symptoms, ...

Edwards Lifesciences (NYSE: EW) and Boston Scientific (NYSE: BSX) both reported strong quarters, but the results reveal ...

Stormont Vail Health in Topeka recently marked the 50-year anniversary of providing cardio-thoracic surgery.

February is American Heart Month, a time to spread awareness about heart health and sometimes problems with the heart that ...

Kasturba Hospital, Manipal, has set a new benchmark in cardiac care by successfully performing South Karnataka’s first Transcatheter Mitral Valve Replacement (TMVR), a minimally invasive procedure, ...